Lv1
40 积分 2026-05-18 加入
Intranasal delivery of a ROS-activatable myeloperoxidase inhibitor alleviates Alzheimer’s-like symptoms and pathology
2天前
已完结
T cell engagers emerge as a compelling therapeutic modality
2个月前
已完结
A translational framework for extrahepatic oligonucleotide delivery
2个月前
已完结
Novel single-domain antibodies targeting a unique transferrin receptor 1 epitope for cross-species delivery of drugs in the central nervous system
2个月前
已完结
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier
2个月前
已完结
Therapeutic targeting of neuroimmune mechanisms in neurodegeneration
3个月前
已完结
1403 A bispecific antibody targeting PD1 and CD40 displays potent anti-tumor efficacy through two mechanisms: PD1 blockade and PD1-dependent CD40 agonism
3个月前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
4个月前
已完结
RYK is a GPNMB receptor that drives MASH
6个月前
已完结